aluates Reports

$ 0.0

Automative

Global Neuropathic Pain Management Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-0H6303

Global Neuropathic Pain Management Market Insights and Forecast to 2028

BUY CHAPTERS

Global Neuropathic Pain Management Market Insights, Forecast to 2030

Code: QYRE-Auto-0H6303

Report

December 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson Services

Sanofi

GlaxoSmithKline PLC

Eli Lilly and Company

Bristol–Myers Squibb

Biogen Idec

Baxter Healthcare Corporation

Depomed

Neuropathic Pain Management Market Size

The global Neuropathic Pain Management market is projected to grow from US$ 8832.3 million in 2024 to US$ 10690 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.

Neuropathic Pain Management Market

Neuropathic pain management refers to a way to relieve and treat neuropathic pain through various drugs or treatments.

Market Analysis and Insights: Global Neuropathic Pain Management Market

The US & Canada market for Neuropathic Pain Management is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Neuropathic Pain Management is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Neuropathic Pain Management is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Neuropathic Pain Management include Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation and Depomed, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Neuropathic Pain Management is widely used in various fields, such as Retail Pharmacy, Hospital Pharmacy and Other,, etc. Retail Pharmacy provides greatest supports to the Neuropathic Pain Management industry development. In 2023, global % revenue of Neuropathic Pain Management went into Retail Pharmacy filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Neuropathic Pain Management market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neuropathic Pain Management, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Neuropathic Pain Management, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuropathic Pain Management revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neuropathic Pain Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neuropathic Pain Management revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Neuropathic Pain Management Market Report

Report Metric	Details
Report Name	Neuropathic Pain Management Market
Accounted market size in 2024	US$ 8832.3 million
Forecasted market size in 2030	US$ 10690 million
CAGR	3.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Tricyclic Antidepressant Anticonvulsant Opioid Steroid Drug Local Anesthesia Other
Segment by Application	Retail Pharmacy Hospital Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation, Depomed
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Neuropathic Pain Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathic Pain Management companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuropathic Pain Management revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Neuropathic Pain Management Market growing?

Ans: The Neuropathic Pain Management Market witnessing a CAGR of 3.2 during the forecast period 2025-2030.

What is the Neuropathic Pain Management Market size in 2030?

Ans: The Neuropathic Pain Management Market size in 2030 will be US$ 10690 million.

Who are the main players in the Neuropathic Pain Management Market report?

Ans: The main players in the Neuropathic Pain Management Market are Pfizer, Johnson & Johnson Services, Sanofi, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, Biogen Idec, Baxter Healthcare Corporation, Depomed

What are the Application segmentation covered in the Neuropathic Pain Management Market report?

Ans: The Applications covered in the Neuropathic Pain Management Market report are Retail Pharmacy, Hospital Pharmacy, Other

What are the Type segmentation covered in the Neuropathic Pain Management Market report?

Ans: The Types covered in the Neuropathic Pain Management Market report are Tricyclic Antidepressant, Anticonvulsant, Opioid, Steroid Drug, Local Anesthesia, Other

Recommended Reports

Pain Management

Neuropathy & Neurology

Chronic & Specific Pain

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neuropathic Pain Management Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Tricyclic Antidepressant

1.2.3 Anticonvulsant

1.2.4 Opioid

1.2.5 Steroid Drug

1.2.6 Local Anesthesia

1.2.7 Other

1.3 Market by Application

1.3.1 Global Neuropathic Pain Management Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Retail Pharmacy

1.3.3 Hospital Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neuropathic Pain Management Market Perspective (2019-2030)

2.2 Global Neuropathic Pain Management Growth Trends by Region

2.2.1 Neuropathic Pain Management Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Neuropathic Pain Management Historic Market Size by Region (2019-2024)

2.2.3 Neuropathic Pain Management Forecasted Market Size by Region (2025-2030)

2.3 Neuropathic Pain Management Market Dynamics

2.3.1 Neuropathic Pain Management Industry Trends

2.3.2 Neuropathic Pain Management Market Drivers

2.3.3 Neuropathic Pain Management Market Challenges

2.3.4 Neuropathic Pain Management Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Neuropathic Pain Management by Players

3.1.1 Global Neuropathic Pain Management Revenue by Players (2019-2024)

3.1.2 Global Neuropathic Pain Management Revenue Market Share by Players (2019-2024)

3.2 Global Neuropathic Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Neuropathic Pain Management, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Neuropathic Pain Management Market Concentration Ratio

3.4.1 Global Neuropathic Pain Management Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Management Revenue in 2023

3.5 Global Key Players of Neuropathic Pain Management Head office and Area Served

3.6 Global Key Players of Neuropathic Pain Management, Product and Application

3.7 Global Key Players of Neuropathic Pain Management, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Pain Management Breakdown Data by Type

4.1 Global Neuropathic Pain Management Historic Market Size by Type (2019-2024)

4.2 Global Neuropathic Pain Management Forecasted Market Size by Type (2025-2030)

5 Neuropathic Pain Management Breakdown Data by Application

5.1 Global Neuropathic Pain Management Historic Market Size by Application (2019-2024)

5.2 Global Neuropathic Pain Management Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Neuropathic Pain Management Market Size (2019-2030)

6.2 North America Neuropathic Pain Management Market Size by Type

6.2.1 North America Neuropathic Pain Management Market Size by Type (2019-2024)

6.2.2 North America Neuropathic Pain Management Market Size by Type (2025-2030)

6.2.3 North America Neuropathic Pain Management Market Share by Type (2019-2030)

6.3 North America Neuropathic Pain Management Market Size by Application

6.3.1 North America Neuropathic Pain Management Market Size by Application (2019-2024)

6.3.2 North America Neuropathic Pain Management Market Size by Application (2025-2030)

6.3.3 North America Neuropathic Pain Management Market Share by Application (2019-2030)

6.4 North America Neuropathic Pain Management Market Size by Country

6.4.1 North America Neuropathic Pain Management Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Neuropathic Pain Management Market Size by Country (2019-2024)

6.4.3 North America Neuropathic Pain Management Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Neuropathic Pain Management Market Size (2019-2030)

7.2 Europe Neuropathic Pain Management Market Size by Type

7.2.1 Europe Neuropathic Pain Management Market Size by Type (2019-2024)

7.2.2 Europe Neuropathic Pain Management Market Size by Type (2025-2030)

7.2.3 Europe Neuropathic Pain Management Market Share by Type (2019-2030)

7.3 Europe Neuropathic Pain Management Market Size by Application

7.3.1 Europe Neuropathic Pain Management Market Size by Application (2019-2024)

7.3.2 Europe Neuropathic Pain Management Market Size by Application (2025-2030)

7.3.3 Europe Neuropathic Pain Management Market Share by Application (2019-2030)

7.4 Europe Neuropathic Pain Management Market Size by Country

7.4.1 Europe Neuropathic Pain Management Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Neuropathic Pain Management Market Size by Country (2019-2024)

7.4.3 Europe Neuropathic Pain Management Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Neuropathic Pain Management Market Size (2019-2030)

8.2 China Neuropathic Pain Management Market Size by Type

8.2.1 China Neuropathic Pain Management Market Size by Type (2019-2024)

8.2.2 China Neuropathic Pain Management Market Size by Type (2025-2030)

8.2.3 China Neuropathic Pain Management Market Share by Type (2019-2030)

8.3 China Neuropathic Pain Management Market Size by Application

8.3.1 China Neuropathic Pain Management Market Size by Application (2019-2024)

8.3.2 China Neuropathic Pain Management Market Size by Application (2025-2030)

8.3.3 China Neuropathic Pain Management Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Neuropathic Pain Management Market Size (2019-2030)

9.2 Asia Neuropathic Pain Management Market Size by Type

9.2.1 Asia Neuropathic Pain Management Market Size by Type (2019-2024)

9.2.2 Asia Neuropathic Pain Management Market Size by Type (2025-2030)

9.2.3 Asia Neuropathic Pain Management Market Share by Type (2019-2030)

9.3 Asia Neuropathic Pain Management Market Size by Application

9.3.1 Asia Neuropathic Pain Management Market Size by Application (2019-2024)

9.3.2 Asia Neuropathic Pain Management Market Size by Application (2025-2030)

9.3.3 Asia Neuropathic Pain Management Market Share by Application (2019-2030)

9.4 Asia Neuropathic Pain Management Market Size by Region

9.4.1 Asia Neuropathic Pain Management Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Neuropathic Pain Management Market Size by Region (2019-2024)

9.4.3 Asia Neuropathic Pain Management Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Type

10.2.1 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Neuropathic Pain Management Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Application

10.3.1 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Neuropathic Pain Management Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country

10.4.1 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Neuropathic Pain Management Introduction

11.1.4 Pfizer Revenue in Neuropathic Pain Management Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Johnson & Johnson Services

11.2.1 Johnson & Johnson Services Company Details

11.2.2 Johnson & Johnson Services Business Overview

11.2.3 Johnson & Johnson Services Neuropathic Pain Management Introduction

11.2.4 Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2019-2024)

11.2.5 Johnson & Johnson Services Recent Developments

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Neuropathic Pain Management Introduction

11.3.4 Sanofi Revenue in Neuropathic Pain Management Business (2019-2024)

11.3.5 Sanofi Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Neuropathic Pain Management Introduction

11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Eli Lilly and Company

11.5.1 Eli Lilly and Company Company Details

11.5.2 Eli Lilly and Company Business Overview

11.5.3 Eli Lilly and Company Neuropathic Pain Management Introduction

11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2019-2024)

11.5.5 Eli Lilly and Company Recent Developments

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Neuropathic Pain Management Introduction

11.6.4 Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Developments

11.7 Biogen Idec

11.7.1 Biogen Idec Company Details

11.7.2 Biogen Idec Business Overview

11.7.3 Biogen Idec Neuropathic Pain Management Introduction

11.7.4 Biogen Idec Revenue in Neuropathic Pain Management Business (2019-2024)

11.7.5 Biogen Idec Recent Developments

11.8 Baxter Healthcare Corporation

11.8.1 Baxter Healthcare Corporation Company Details

11.8.2 Baxter Healthcare Corporation Business Overview

11.8.3 Baxter Healthcare Corporation Neuropathic Pain Management Introduction

11.8.4 Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2019-2024)

11.8.5 Baxter Healthcare Corporation Recent Developments

11.9 Depomed

11.9.1 Depomed Company Details

11.9.2 Depomed Business Overview

11.9.3 Depomed Neuropathic Pain Management Introduction

11.9.4 Depomed Revenue in Neuropathic Pain Management Business (2019-2024)

11.9.5 Depomed Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Johnson & Johnson Services

Sanofi

GlaxoSmithKline PLC

Eli Lilly and Company

Bristol–Myers Squibb

Biogen Idec

Baxter Healthcare Corporation

Depomed

List of Tables

Table 1. Global Neuropathic Pain Management Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Tricyclic Antidepressant

Table 3. Key Players of Anticonvulsant

Table 4. Key Players of Opioid

Table 5. Key Players of Steroid Drug

Table 6. Key Players of Local Anesthesia

Table 7. Key Players of Other

Table 8. Global Neuropathic Pain Management Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Neuropathic Pain Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Neuropathic Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Neuropathic Pain Management Market Share by Region (2019-2024)

Table 12. Global Neuropathic Pain Management Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Neuropathic Pain Management Market Share by Region (2025-2030)

Table 14. Neuropathic Pain Management Market Trends

Table 15. Neuropathic Pain Management Market Drivers

Table 16. Neuropathic Pain Management Market Challenges

Table 17. Neuropathic Pain Management Market Restraints

Table 18. Global Neuropathic Pain Management Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Neuropathic Pain Management Revenue Share by Players (2019-2024)

Table 20. Global Top Neuropathic Pain Management by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Management as of 2023)

Table 21. Global Neuropathic Pain Management Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Management Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Neuropathic Pain Management, Headquarters and Area Served

Table 24. Global Key Players of Neuropathic Pain Management, Product and Application

Table 25. Global Key Players of Neuropathic Pain Management, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Neuropathic Pain Management Revenue Market Share by Type (2019-2024)

Table 29. Global Neuropathic Pain Management Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Neuropathic Pain Management Revenue Market Share by Type (2025-2030)

Table 31. Global Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Neuropathic Pain Management Revenue Share by Application (2019-2024)

Table 33. Global Neuropathic Pain Management Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Neuropathic Pain Management Revenue Share by Application (2025-2030)

Table 35. North America Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Neuropathic Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Neuropathic Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Neuropathic Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Neuropathic Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Neuropathic Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Neuropathic Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Neuropathic Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Neuropathic Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Neuropathic Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Neuropathic Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Neuropathic Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Neuropathic Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Neuropathic Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Neuropathic Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Neuropathic Pain Management Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Neuropathic Pain Management Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Neuropathic Pain Management Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Neuropathic Pain Management Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size by Country (2025-2030) & (US$ Million)

Table 67. Pfizer Company Details

Table 68. Pfizer Business Overview

Table 69. Pfizer Neuropathic Pain Management Product

Table 70. Pfizer Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 71. Pfizer Recent Developments

Table 72. Johnson & Johnson Services Company Details

Table 73. Johnson & Johnson Services Business Overview

Table 74. Johnson & Johnson Services Neuropathic Pain Management Product

Table 75. Johnson & Johnson Services Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 76. Johnson & Johnson Services Recent Developments

Table 77. Sanofi Company Details

Table 78. Sanofi Business Overview

Table 79. Sanofi Neuropathic Pain Management Product

Table 80. Sanofi Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 81. Sanofi Recent Developments

Table 82. GlaxoSmithKline Company Details

Table 83. GlaxoSmithKline Business Overview

Table 84. GlaxoSmithKline Neuropathic Pain Management Product

Table 85. GlaxoSmithKline Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 86. GlaxoSmithKline Recent Developments

Table 87. Eli Lilly and Company Company Details

Table 88. Eli Lilly and Company Business Overview

Table 89. Eli Lilly and Company Neuropathic Pain Management Product

Table 90. Eli Lilly and Company Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 91. Eli Lilly and Company Recent Developments

Table 92. Bristol-Myers Squibb Company Details

Table 93. Bristol-Myers Squibb Business Overview

Table 94. Bristol-Myers Squibb Neuropathic Pain Management Product

Table 95. Bristol-Myers Squibb Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 96. Bristol-Myers Squibb Recent Developments

Table 97. Biogen Idec Company Details

Table 98. Biogen Idec Business Overview

Table 99. Biogen Idec Neuropathic Pain Management Product

Table 100. Biogen Idec Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 101. Biogen Idec Recent Developments

Table 102. Baxter Healthcare Corporation Company Details

Table 103. Baxter Healthcare Corporation Business Overview

Table 104. Baxter Healthcare Corporation Neuropathic Pain Management Product

Table 105. Baxter Healthcare Corporation Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 106. Baxter Healthcare Corporation Recent Developments

Table 107. Depomed Company Details

Table 108. Depomed Business Overview

Table 109. Depomed Neuropathic Pain Management Product

Table 110. Depomed Revenue in Neuropathic Pain Management Business (2019-2024) & (US$ Million)

Table 111. Depomed Recent Developments

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Neuropathic Pain Management Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Neuropathic Pain Management Market Share by Type: 2023 VS 2030

Figure 3. Tricyclic Antidepressant Features

Figure 4. Anticonvulsant Features

Figure 5. Opioid Features

Figure 6. Steroid Drug Features

Figure 7. Local Anesthesia Features

Figure 8. Other Features

Figure 9. Global Neuropathic Pain Management Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Neuropathic Pain Management Market Share by Application: 2023 VS 2030

Figure 11. Retail Pharmacy Case Studies

Figure 12. Hospital Pharmacy Case Studies

Figure 13. Other Case Studies

Figure 14. Neuropathic Pain Management Report Years Considered

Figure 15. Global Neuropathic Pain Management Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Neuropathic Pain Management Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Neuropathic Pain Management Market Share by Region: 2023 VS 2030

Figure 18. Global Neuropathic Pain Management Market Share by Players in 2023

Figure 19. Global Top Neuropathic Pain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropathic Pain Management as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Neuropathic Pain Management Revenue in 2023

Figure 21. North America Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Neuropathic Pain Management Market Share by Type (2019-2030)

Figure 23. North America Neuropathic Pain Management Market Share by Application (2019-2030)

Figure 24. North America Neuropathic Pain Management Market Share by Country (2019-2030)

Figure 25. United States Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Neuropathic Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Neuropathic Pain Management Market Share by Type (2019-2030)

Figure 29. Europe Neuropathic Pain Management Market Share by Application (2019-2030)

Figure 30. Europe Neuropathic Pain Management Market Share by Country (2019-2030)

Figure 31. Germany Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Neuropathic Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Neuropathic Pain Management Market Share by Type (2019-2030)

Figure 39. China Neuropathic Pain Management Market Share by Application (2019-2030)

Figure 40. Asia Neuropathic Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Neuropathic Pain Management Market Share by Type (2019-2030)

Figure 42. Asia Neuropathic Pain Management Market Share by Application (2019-2030)

Figure 43. Asia Neuropathic Pain Management Market Share by Region (2019-2030)

Figure 44. Japan Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Neuropathic Pain Management Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Neuropathic Pain Management Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Neuropathic Pain Management Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Neuropathic Pain Management Market Share by Country (2019-2030)

Figure 54. Brazil Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Neuropathic Pain Management Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Pfizer Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 61. Johnson & Johnson Services Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 63. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 64. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 66. Biogen Idec Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 67. Baxter Healthcare Corporation Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 68. Depomed Revenue Growth Rate in Neuropathic Pain Management Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neuropathic Pain Drugs Market Research Report 2024

Neuropathy Pain Treatment Market

Global Drugs for Pain Management Market Insights Forecast to 2030

Global Pets Pain Management Market Insights Forecast to 2030

Optic Neuropathy Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Pain Management Market Insights Forecast to 2030

Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024

Global Companion Animal Pain Management Market Insights Forecast to 2030

Global Ocular Neuropathic Pain Market Research Report 2024

Global Pain Management Therapie Market Research Report 2024

Global Non Opioid Pain Treatment Market Insights Forecast to 2030

Global Livestock Pain Management Market Insights Forecast to 2030

Global Pain Management and Surgical Devices Market Insights Forecast to 2030

Global Pain Management Drugs Market Research Report 2025

Global Farm Animal Pain Management Market Insights Forecast to 2030

Global Veterinary Pain Treatment Market Research Report 2025

Global Pain Management Information System Market Research Report 2024

Global Scoliosis Management Market Insights Forecast to 2030

Wound Care Treatment and Management Market

RELATED REPORTS

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Fentanyl Transdermal Patches Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6E8391

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Knee Pain Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L1859

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Peripheral Neuropathy Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17R6157

Fri Sep 05 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions